An Increasing Incidence of GEP-NETs in Chengdu City with a Population of 14 Million in China Abstract #390

Introduction: The annual incidence of GEP-NETs in China is still unclear. All histopathology and cytopathology reports have yet to be collected in a national archive. No national or regional survey on GEP-NETs has been approved. West China Hospital (WCH), a university hospital located in Chengdu City with a population of 14 million, has established a series of databases in recent years.
Aim(s): To estimate the incidence of GEP-NETs in Chengdu with the database of WCH and population-based data from Chengdu during 2006 – 2010.
Materials and methods: The annual number of patients in WCH was between 25.6% and 28% of those diagnosed with GEP-NETs in Chengdu during the past five years. GEP-NETs incidence in Chengdu was yielded by the number of annual new patients with GEP-NETs in WCH divided by the 25.6% - 28% population of Chengdu.
Conference: 9th Annual ENETS Conference (2012)
Category: Clinical
Presenting Author: Professor Tang Chengwei

To read results and conclusion, please login ...

Further abstracts you may be interested in

#1058 Epidemiologic Analysis of Neuroendocrine Tumors in Cancer Center: Tianjin, China
Introduction: An increased incidence of neuroendocrine tumors (NETs) has been reported worldwide.
Conference: 12th Annual ENETS Conference (2015)
Category: Epidemiology/Natural history/Prognosis - Descriptive epidemiology
Presenting Author: Dr. Jian Wang
Authors: Wang J, Sun Y S, Wang X, Hao J
#1365 Exploring the Rising Incidence of Gastroenteropancreatic Neuroendocrine Tumors According to the Data from Regional Cancer Registry: A Population-Based Analysis of Epidemiology
Introduction: The incidence of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) is reported to arise worldwide. Similar tendency is observed in Bulgaria during the recent 6 years.
Conference: 13th Annual ENETS conference (2016)
Category: Epidemiology/Natural history/Prognosis - Registries, nationwide and regional surveys
Presenting Author: Paulina Vladova
#932 Hematological Toxicity of Combined Lutetium-177 Octreotate Radiopeptide-Chemotherapy of Gastroenteropancreatic Neuroendocrine Tumors Followed Long-Term
Introduction: Combination radiopeptide therapy (PRRT) with radiosensitizing chemotherapy of gastroenteropancreatic neuroendocrine tumors (GEP NETs) may improve efficacy, but has the potential to increase myelotoxicity.
Conference: 11th Annual ENETS Conference (2014)
Category: PRRT-Ablative therapies-Endoscopic treatment
Presenting Author: Dr Murali Kesavan
Keywords: PRRT, GEP-NET
#1441 Epidemiology and Treatment Strategy of Neuroendocrine Neoplasms in North China
Introduction: Few studies had focus on the epidemiology of neuroendocrine neoplasms (NENs) , a rare disease, in China.
Conference: 13th Annual ENETS conference (2016)
Category: Epidemiology/Natural history/Prognosis - Descriptive epidemiology
Presenting Author: Qian-Nan Wang
Authors: Wang Q N, Jia R, Chen Y, Zhao C H, ...
#1594 The Epidemiological Study of Neuroendocrine Neoplasms: A Single-Center Retrospective Analysis of 710 Patients in China
Introduction: China hasn’t established a national database of NENs yet, thus, this epidemiological report is based on a single-center retrospective analysis.
Conference: 14th Annual ENETS conference (2017)
Category: Epidemiology/Natural history/Prognosis - Registries, nationwide and regional surveys
Presenting Author: Prof. Huang-Ying Tan
Authors: Qiu X D, Zhang P, Luo J, Liu J X, ...
Keywords: NEN, epidemiology